The biotechnology market experiences significant growth, fueled by advancements in genetic therapies and supportive global ...

However, the company developed its competitive edge with the Trikafta treatment getting approved ... Vertex Pharmaceuticals ...

But when something this big happens with VRTX, it often means somebody knows ... Anticipated earnings release is in 47 days. Benzinga Edge's Unusual Options board spots potential market movers ...

Price Action: VRTX stock is up 2.16% at $472.06 at last check Monday. UNLOCKED: 5 NEW TRADES EVERY WEEK. Click now to get top trade ideas daily, plus unlimited access to cutting-edge tools and ...

Price Action: VRTX stock is down 13.4% at $387.37 at last check Thursday. UNLOCKED: 5 NEW TRADES EVERY WEEK. Click now to get top trade ideas daily, plus unlimited access to cutting-edge tools and ...